Literature DB >> 3111880

Anticonvulsant drugs in monotherapy. Effect on the fetus.

R Bertollini, B Källen, P Mastroiacovo, E Robert.   

Abstract

We describe a material of 577 infants born of epileptic women treated with anticonvulsants in monotherapy during early pregnancy and collected from France, Italy, and Sweden. The incidence of major malformations is increased compared with the general population but no definite difference in risk can be demonstrated between the various anticonvulsants, but valproic acid was associated with a doubling of the average risk. The increased risk for facial clefts and for cardiac malformations, described from most studies on epilepsy during pregnancy, cannot be seen in this material. Unusually many cases of penis abnormalities (micropenis, hypospadias) were noted. An effect on fetal growth can be demonstrated and is apparently more pronounced for carbamazepine than for the other drugs. It results in a reduced birth weight in spite of normal gestational length, reduced body length and head circumference. The possible biological significance of this finding is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111880     DOI: 10.1007/bf00239754

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  12 in total

1.  [Children exposed in utero to antiepileptic drugs].

Authors:  M Béthenod; A Frédérich
Journal:  Pediatrie       Date:  1975 Apr-May

2.  [ARE ANTI-EPILEPTIC DRUGS HARMFUL DURING PREGNANCY?].

Authors:  D JANZ; U FUCHS
Journal:  Dtsch Med Wochenschr       Date:  1964-02-07       Impact factor: 0.628

3.  Anticonvulsant drugs and congenital abnormalities.

Authors:  S R Meadow
Journal:  Lancet       Date:  1968-12-14       Impact factor: 79.321

4.  Infants exposed in utero to antiepileptic drugs. A prospective study.

Authors:  R M Hill; W M Verniaud; M G Horning; L B McCulley; N F Morgan
Journal:  Am J Dis Child       Date:  1974-05

5.  Birth weight distribution as an indicator of environmental effects on fetal development.

Authors:  A Ericson; M Eriksson; B Källén; O Meirik
Journal:  Scand J Soc Med       Date:  1987

6.  Valproate and spina bifida.

Authors:  E Robert; E Löfkvist; F Mauguiere
Journal:  Lancet       Date:  1984-12-15       Impact factor: 79.321

7.  Fetal head growth retardation associated with maternal antiepileptic drugs.

Authors:  V K Hiilesmaa; K Teramo; M L Granström; A H Bardy
Journal:  Lancet       Date:  1981-07-25       Impact factor: 79.321

8.  [Congenital abnormalities, cleft lip and cleft palate in particular, in children of epileptic mothers].

Authors:  J Elshove; J H van Eck
Journal:  Ned Tijdschr Geneeskd       Date:  1971-08-14

9.  Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome.

Authors:  J W Hanson; N C Myrianthopoulos; M A Harvey; D W Smith
Journal:  J Pediatr       Date:  1976-10       Impact factor: 4.406

10.  The fetal trimethadione syndrome: report of an additional family and further delineation of this syndrome.

Authors:  G L Feldman; D D Weaver; E W Lovrien
Journal:  Am J Dis Child       Date:  1977-12
View more
  11 in total

1.  Teratogenic effect of carbamazepine.

Authors:  V Vestermark; S Vestermark
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

2.  An international case-control study on hypospadias. The problem with variability and the beauty of diversity.

Authors:  B Källén; E E Castilla; E Robert; P A Lancaster; M Kringelbach; O Mutchinick; M L Martínez-Frias; P Mastroiacovo
Journal:  Eur J Epidemiol       Date:  1992-03       Impact factor: 8.082

3.  Teratogenic Effects of `Recreational' Drugs: Increasing the risk of congenital anomalies.

Authors:  J E Polifka; J M Friedman
Journal:  Can Fam Physician       Date:  1991-09       Impact factor: 3.275

Review 4.  Clinical teratology.

Authors:  A Ornoy; J Arnon
Journal:  West J Med       Date:  1993-09

5.  Anticonvulsant drugs and malformations is there a drug specificity?

Authors:  B Källén; E Robert; P Mastroiacovo; M L Martínez-Frías; E E Castilla; G Cocchi
Journal:  Eur J Epidemiol       Date:  1989-03       Impact factor: 8.082

Review 6.  Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts.

Authors:  Kimford Meador; Matthew W Reynolds; Sheila Crean; Kyle Fahrbach; Corey Probst
Journal:  Epilepsy Res       Date:  2008-06-18       Impact factor: 3.045

7.  Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.

Authors:  E Thisted; F Ebbesen
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

Review 8.  Management of epilepsy during pregnancy.

Authors:  Dina Battino; Torbjörn Tomson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Pregnancy outcome after in utero exposure to valproate : evidence of dose relationship in teratogenic effect.

Authors:  Orna Diav-Citrin; Svetlana Shechtman; Benjamin Bar-Oz; Dana Cantrell; Judy Arnon; Asher Ornoy
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

10.  Risk of hypospadias in newborn infants exposed to valproic acid during the first trimester of pregnancy: a case-control study in Spain.

Authors:  Elvira Rodríguez-Pinilla; Consuelo Mejías; David Prieto-Merino; Paloma Fernández; María L Martínez-Frías
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.